Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 2, 2006 - Issue 2
Submit an article Journal homepage
39
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting

Luiz DratcuYork Clinic, Guy’s Hospital, South London and Maudsley NHS Trust, London, UKCorrespondence[email protected]
,
Patricia OlowuYork Clinic, Guy’s Hospital, South London and Maudsley NHS Trust, London, UK
,
Muzafar HawramyYork Clinic, Guy’s Hospital, South London and Maudsley NHS Trust, London, UK
&
Charitomeni KonstantinidouYork Clinic, Guy’s Hospital, South London and Maudsley NHS Trust, London, UK
Pages 191-197 | Published online: 25 Nov 2022

References

  • AlvirJMLiebermanJDSattermanAZ1993Clozapine-induced agranulocytosis. Incidence and risk factors in the United StatesN Engl J Med32916278515788
  • BarbeeJGConradEJJamhourNJ2004Aripiprazole augmentation in treatment-resistant depressionAnn Clin Psychiatry161899415702566
  • BechPKastrupMRafaelsenOJ1986Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromesActa Psychiatr Scand73Suppl 326326
  • BurrisKDMolskiTFXuC2002Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsJ Pharmacol Exp Ther302381912065741
  • CarlssonAHealyD1996The rise of psychopharmacology: impact on basic and clinical neuroscienceThe psychopharmacologistsLondonChapman and Hall5180
  • ChakrabortyNJohnstonT2005Aripiprazole and neuroleptic malignant syndromeInt Clin Psychopharmacol19351315486522
  • CohenSTRulfDPiesR2005Extrapyramidal side effects associated with aripiprazole co-prescription in two patientsJ Clin Psychiatry66135615669901
  • ConnorKMPayneVMGaddeKM2005The use of aripiprazole in obsessive-compulsive patients: preliminary observations in 8 patientsJ Clin Psychiatry66495115669888
  • DratcuLGrandisonAAdkinA2003Acute hospital care in inner London: splitting from mental health services in the communityPsychiatr Bull27836
  • DuggalHS2003Aripiprazole-induced improvement in tardive dyskinesiaCan J Psychiatry48771214733461
  • GoldsteinJM2000The new generation of antipsychotic drugs: how atypical are they?Int J Neuropsychopharmacol33394911343614
  • KaneJMCarsonWHSahaAR2002Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorderJ Clin Psychiatry637637112363115
  • KasperSLermanNMcQuadeRD2003Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophreniaInt J Neuropsychopharmacol6325714609439
  • KastrupASchlotterWPlewniaC2005Treatment of tics in Tourette syndrome with aripiprazoleJ Clin Psychiatry256496
  • MarderSRMcQuadeRDStockE2003Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo controlled trialsSchizophr Res611233612729864
  • McGavinJKGoaKL2002AripiprazoleCNS Drugs167798612383035
  • McLeanAJ2004The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndromeSleep27102215453563
  • MendhekarDN2004Aripiprazole-induced rabbit syndromeAust N Z J Psychiatry3856115255832
  • [NICE] National Institute for Clinical Excellence2002Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia Technology Appraisal Guidance No. 43LondonNICE
  • PigottTECarsonWHSahaAR2003Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week studyJ Clin Psychiatry6410485614628980
  • PotkinSGSahaARKukawaMJ2003Aripiprazole, an antipsychotic with a novel mode of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorderArch Gen Psychiatry606819012860772
  • SajbelTACheneyEMDequardoJR2005Aripiprazole-associated dyskinesiaAnn Pharmacother39200115598969
  • StallerJA2003Aripiprazole in an adult with Asperger disorderAnn Pharmacother3716283114565842
  • TammingaCAWoernerMGDavisKLCharneyDCoyleJT2002Clinical course and cellular pathology of tardive dyskinesiaNeuropsychopharmacology The fifth generation of progressPhiladelphiaLippincott Williams & Wilkins183141
  • [WHO] World Health Organization1994ICD-10 Classification of Mental and Behavioural DisordersGenevaWHO

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.